This proposal is the second competitive renewal for a training program in AIDS pathogenesis research for M.D. and/or Ph.D. postdoctoral fellows. The program design provides structured training, including basic science and biostatistics courses, conferences, manuscript and grant writing activity and experience in dealing with ethical issues in research and human experimentation in such manner as most effectively will complement supervised research in the laboratory of an accomplished faculty mentor. Our program is also organized to insure that all trainees, whether M.D.s or Ph.D.s, will learn not only the scientific, but also the compelling human issues of HIV/AIDS and how to address them so that research priorities can best reflect clinical needs and opportunities. Our faculty's interests include basic issues in HIV replication and virus growth regulation, immunology and immunotherapy, molecular mechanisms in opportunistic infections, and pathogenesis of HIV and its complications. New faculty members have been added to expand the training opportunities in the areas of the metabolic disorders associated with HIV and HIV therapy, the biology of HIV-associated neurologic diseases, and studies of pharmacologic aspects attendant to HIV-related therapeutics. These new areas of HIV-related research represent part of the expansion of HIV/AIDS research at New England Medical Center that led to the award of the NIH-funded Lifespan-Tufts-Brown Center for AIDS Research in 1998. An Executive Committee, with the assistance of appropriate administrative staff and structure, oversees program operations including the fellowship selection process, communications, and monitoring of trainees' laboratory progress. We have developed and are continuing to refine specific policies and procedures to increase the number of underrepresented ethnic/racial minorities that apply for this training opportunity. The success of our trainees and training program for the first 10 years of operation are outlined, and plans for the next 5 years of training opportunities are detailed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007389-12
Application #
6510243
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Program Officer
Sharma, Opendra K
Project Start
1990-08-01
Project End
2006-07-30
Budget Start
2002-08-01
Budget End
2003-07-31
Support Year
12
Fiscal Year
2002
Total Cost
$267,366
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02111
Alvarez, Samantha W; Sviderskiy, Vladislav O; Terzi, Erdem M et al. (2017) NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature 551:639-643
Dinh, Duy M; Ramadass, Balamurugan; Kattula, Deepthi et al. (2016) Longitudinal Analysis of the Intestinal Microbiota in Persistently Stunted Young Children in South India. PLoS One 11:e0155405
Dinh, Duy M; Volpe, Gretchen E; Duffalo, Chad et al. (2015) Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J Infect Dis 211:19-27
Kim, Dohoon; Fiske, Brian P; Birsoy, Kivanc et al. (2015) SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature 520:363-7
Birsoy, K?vanç; Possemato, Richard; Lorbeer, Franziska K et al. (2014) Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature 508:108-12
Martz, Colin A; Ottina, Kathleen A; Singleton, Katherine R et al. (2014) Systematic identification of signaling pathways with potential to confer anticancer drug resistance. Sci Signal 7:ra121
Veeranagouda, Yaligara; Husain, Fasahath; Tenorio, Elizabeth L et al. (2014) Identification of genes required for the survival of B. fragilis using massive parallel sequencing of a saturated transposon mutant library. BMC Genomics 15:429
Wanyiri, Jane W; Kanyi, Henry; Maina, Samuel et al. (2014) Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses. Am J Trop Med Hyg 91:319-28
Grabiner, Brian C; Nardi, Valentina; Birsoy, K?vanc et al. (2014) A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov 4:554-63
Chen, Walter W; Birsoy, Kivanc; Mihaylova, Maria M et al. (2014) Inhibition of ATPIF1 ameliorates severe mitochondrial respiratory chain dysfunction in mammalian cells. Cell Rep 7:27-34

Showing the most recent 10 out of 48 publications